815. Deputy Denise Mitchell asked the Minister for Health the progress being made towards making the drugs enhertu, zongertinib and sevabertinib, which are used to treat HER2 cancers, available for use in Ireland; her plans to make enhertu - which has been recommended for approval by the European medicines agency- available via an early access scheme; her plans to conduct clinical trials using these drugs in Ireland; and if she will make a statement on the matter. [68774/26]

Summary

815. Deputy Denise Mitchell asked the Minister for Health the progress being made towards making the drugs enhertu, zongertinib and sevabertinib, which are used to treat HER2 cancers, available for use in Ireland; her plans to make enhertu - which has been recommended for approval by the European medicines agency- available via an early access scheme; her plans to conduct clinical trials using these drugs in Ireland; and if she will make a statement on the matter. [68774/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 29 September 2026

   Healthcare Policy

   815. Deputy Denise Mitchell asked the Minister for Health the progress being made towards making the drugs enhertu, zongertinib and sevabertinib, which are used to treat HER2 cancers, available for use in Ireland; her plans to make enhertu - which has been recommended for approval by the European medicines agency- available via an early access scheme; her plans to conduct clinical trials using these drugs in Ireland; and if she will make a statement on the matter. [68774/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Healthcare Policy

  xml · EN · 29 September 2026

  ViewDownloadOpen at official source

Sponsors

• Denise Mitchell · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.